PLIANT THERAPEUTICS, INC. Proceeds from Common Stock Issued
PLIANT THERAPEUTICS, INC. (PLRX) reported Proceeds from Common Stock Issued of $1.30 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-11-08
- PLIANT THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2019-09-30 was $14.00K.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month |
|---|---|---|---|
| 2022-09-30 | $1.30M 10-Q · filed 2022-11-08 | ||
| 2021-09-30 | $2.44M 10-Q · filed 2022-11-08 | ||
| 2020-09-30 | $205.00K 10-Q · filed 2021-11-09 | ||
| 2019-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $146.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $132.00K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |